HEAD AND NECK RADIOLOGY / ORIGINAL PAPER
Gallium-67 SPECT-CT for the evaluation of head and neck: preliminary study on maximum standardised uptake value in lesions, and in the parotid and submandibular glands
1
Dental Anaesthesia and General Health Management, The Nippon Dental University Niigata Hospital, Niigata, Japan
2
Department of Oral and Maxillofacial Radiology, The Nippon Dental University School of Life Dentistry at Niigata, Niigata, Japan
Submission date: 2019-12-12
Final revision date: 2020-03-06
Acceptance date: 2020-03-11
Publication date: 2020-05-06
Pol J Radiol, 2020; 85: 224-229
KEYWORDS
TOPICS
ABSTRACT
Purpose:
The aim of this study was to investigate the gallium-67 (67Ga) single-photon emission-computed tomography (SPECT-CT) for the evaluation of head and neck, especially maximum standardised uptake value (SUVmax) in lesions, and in the parotid and submandibular glands.
Material and methods:
Fourteen patients with head and neck lesions who underwent SPECT-CT at 72 hours after injection of 67Ga were included in this study. The 67Ga SPECT-CT parameters SUVmax were compared between the parotid glands and submandibular glands. Statistical analyses for the SUVmax were performed by Mann-Whitney U test. A p value lower than 0.05 was considered as statistically significant.
Results:
Of all 14 patients, 67Ga SPECT-CT was positive for two cases (one malignant lymphoma and one osteomyelitis). The SUVmax for malignant lymphoma and osteomyelitis were 11.21 and 10.95, respectively. Furthermore, SUVmax for parotid glands and submandibular glands of all patients were 4.86 ± 1.89 and 4.64 ± 1.64, respectively (p = 0.694).
Conclusions:
This study investigated the 67Ga SPECT-CT for the evaluation of head and neck, especially SUVmax of lesions, and the parotid and submandibular glands. 67Ga SPECT-CT may be an effective technique for the evaluation of maxillofacial lesions.
The aim of this study was to investigate the gallium-67 (67Ga) single-photon emission-computed tomography (SPECT-CT) for the evaluation of head and neck, especially maximum standardised uptake value (SUVmax) in lesions, and in the parotid and submandibular glands.
Material and methods:
Fourteen patients with head and neck lesions who underwent SPECT-CT at 72 hours after injection of 67Ga were included in this study. The 67Ga SPECT-CT parameters SUVmax were compared between the parotid glands and submandibular glands. Statistical analyses for the SUVmax were performed by Mann-Whitney U test. A p value lower than 0.05 was considered as statistically significant.
Results:
Of all 14 patients, 67Ga SPECT-CT was positive for two cases (one malignant lymphoma and one osteomyelitis). The SUVmax for malignant lymphoma and osteomyelitis were 11.21 and 10.95, respectively. Furthermore, SUVmax for parotid glands and submandibular glands of all patients were 4.86 ± 1.89 and 4.64 ± 1.64, respectively (p = 0.694).
Conclusions:
This study investigated the 67Ga SPECT-CT for the evaluation of head and neck, especially SUVmax of lesions, and the parotid and submandibular glands. 67Ga SPECT-CT may be an effective technique for the evaluation of maxillofacial lesions.
REFERENCES (20)
1.
Li N, Zhu W, Zuo S, et al. Value of gallium-67 scanning in differentiation of malignant tumors from benign tumors or inflammatory disease in the oral and maxillofacial region. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2003; 96: 361-367.
2.
Ogura I, Oda T, Sue M, et al. Gallium-67 scintigraphy in differential diagnosis of malignant tumours from non-tumorous lesions of the maxilla. Chin J Dent Res 2017; 20: 219-223.
3.
Ogura I, Sue M, Oda T, et al. Comparison between mandibular malignant tumors and inflammatory lesions using 67Ga scintigraphy: relationship with panoramic radiography, CT and MRI findings. Int J Diagn Imaging 2017; 4: 67-73.
4.
Ogura I, Oda T, Sue M, et al. Comparison between squamous cell carcinoma and inflammatory diseases of the oral and maxillofacial region using gallium-67 scintigraphy with computed tomography and magnetic resonance imaging. Pol J Radiol 2018; 83: e452-458.
5.
Murata Y, Ishida R, Umehara I, et al. 67Ga whole-body scintigraphy in the evaluation of head and neck squamous cell carcinoma. Nucl Med Commun 1999; 20: 599-607.
6.
Kosuda S, Kadota Y, Umeda S, et al. Does supplementation of CT and MRI with gallium-67 SPECT improve the differentiation between benign and malignant tumors of the head and neck? Ann Nucl Med 2003; 17: 475-480.
7.
Okada M, Sato N, Ishii K, et al. FDG PET/CT versus CT, MR imaging, and 67Ga scintigraphy in the posttherapy evaluation of malignant lymphoma. Radiographics 2010; 30: 939-957.
8.
Keijsers RG, Grutters JC, Thomeer M, et al. Imaging the inflammatory activity of sarcoidosis: sensitivity and inter observer agreement of 67Ga imaging and 18F-FDG PET. Q J Nucl Med Mol Imaging 2011; 55: 66-71.
9.
Ishii S, Miyajima M, Sakuma K, et al. Comparison between sarcoidosis and IgG4-related disease by whole-body 67Ga scintigraphy. Nucl Med Commun 2013; 34:13-18.
10.
Shim H, Joo J, Choi HJ, et al. Lack of increased FDG uptake in the lacrimal and salivary glands in patients with sarcoidosis and potential underlying mechanism. Clin Nucl Med 2016; 41: 274-277.
11.
Aslangul E, M’bemba J, Caillat-Vigneron N, et al. Diagnosing diabetic foot osteomyelitis in patients without signs of soft tissue infection by coupling hybrid 67Ga SPECT/CT with bed-side percutaneous bone puncture. Diabetes Care 2013; 36: 2203-2210.
12.
Tsai SC, Hsieh TY, Huang PW, et al. Absolute quantitative evaluation of 67Ga scintigraphy in lupus nephritis. Clin Nucl Med 2016; 41: 442-446.
13.
Suh MS, Lee WW, Km YK, et al. Maximum standardized uptake value of 99mTc hydroxymethylene diphosphonate SPECT/CT for the evaluation of temporomandibular joint disorder. Radiology 2016; 280: 890-896.
14.
Kaneta T, Ogawa M, Daisaki H, et al. SUV measurement of normal vertebrae using SPECT/CT with Tc-99m methylene diphosphonate. Am J Nucl Med Mol Imaging 2016; 6: 262-268.
15.
Kim J, Lee H, Lee H, et al. Quantitative single-photon emission computed tomography/computed tomography for evaluation of salivary gland dysfunction in Sjögren’s syndrome patients. Nucl Med Mol Imaging 2018; 52: 368-376.
16.
Ninomiya K, Toya S, Ogura I. Single-photon emission computed tomography/computed tomography for evaluation of salivary gland dysfunction: preliminary study on diagnostic ability of maximum standardized uptake value. Oral Radiol 2020; 36: 163-167.
17.
Ogura I, Kobayashi E, Nakahara K, et al. Quantitative SPECT/CT imaging for medication-related osteonecrosis of the jaw: a preliminary study using volume-based parameters, comparison with chronic osteomyelitis. Ann Nucl Med 2019; 33: 776-782.
18.
Ogura I, Sasaki Y, Sue M, et al. Tc-99m hydroxymethylene diphosphonate SPECT/CT for the evaluation of osteonecrosis of the jaw: preliminary study on diagnostic ability of maximum standardized uptake value. Clin Radiol 2020; 75: 46-50.
19.
Tsan MF, Scheffel U. Mechanism of gallium-67 accumulation in tumors. J Nucl Med 1986; 27: 1215-1219.
20.
Szyszko TA, Cook GJR. PET/CT and PET/MRI in head and neck malignancy. Clin Radiol 2018; 73: 60-69.
Share
RELATED ARTICLE
We process personal data collected when visiting the website. The function of obtaining information about users and their behavior is carried out by voluntarily entered information in forms and saving cookies in end devices. Data, including cookies, are used to provide services, improve the user experience and to analyze the traffic in accordance with the Privacy policy. Data are also collected and processed by Google Analytics tool (more).
You can change cookies settings in your browser. Restricted use of cookies in the browser configuration may affect some functionalities of the website.
You can change cookies settings in your browser. Restricted use of cookies in the browser configuration may affect some functionalities of the website.
